best starting dose for retatrutide A Clinician's Guide to Dosing Avoid These Retatrutide Mistakes to
Description
Major Update in Obesity Care: New ADA Guidelines (2026) The American Diabetes Association has released new, evidence-based guidance on the pharmacologic treatment of obesity and this is not a minor update

Here, we report a case of NAION in a young patient with diabetes receiving semaglutide (GLP-1 RA), which showed a complete resolution of symptoms after discontinuing the GLP-1 RA

Novo Nordisks GLP-1 drug semaglutide failed to slow the progression of Alzheimers disease in new study results, dashing hopes that GLP-1s might one day be approved to treat the condition

Learn what patients experience, coping tips, and when to seek help.

FDA Approves Oral Semaglutide as a GLP-1 Pill for Weight Loss at Centra Internal Medicine

GLP JDC Burst 1 Hire at IPS
